Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Myasthenia Gravis × Mycophenolic Acid × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Myeloproliferative Disorders 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Hodgkin Disease 3 Graft vs Host Disease 3 Waldenstrom Macroglobulinemia 2 Primary Myelofibrosis 2 Lymphoma 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia 2 Hematologic Neoplasms 2 Testicular Neoplasms 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Myasthenia Gravis 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Prolymphocytic 1 Leukemia, Neutrophilic, Chronic 1

Interventions

rozanolixizumab 6 zilucoplan 5 efgartigimod alfa 5 eculizumab 4 telitacicept 3 Tacrolimus 3 Amifampridine 3 ravulizumab 2 Rituximab 2 Prednisone 2 HBM9161 2 satralizumab 1 remibrutinib 1 iptacopan 1 inebilizumab 1 Thymectomy 1 Sugars 1 Steroids 1 Sodium Chloride 1 Pyridostigmine Bromide 1 Prednisolone 1 Mycophenolic Acid 1 Leflunomide 1 Hizentra 1 Cladribine 1 Azathioprine 1 Alkalies 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00285350 2015-03-25

Mycophenolate Mofetil in Myasthenia Gravis

FDA Office of Orphan Products Development

Phase 3 Completed

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡